Palladia 50 mg 4 x 5 tabletten
Is the registration number of your country not listed? Then this product falls within the cascade control system.
Palladia 50 mg 4 x 5 tabletten
Target species
Dog
Indications
Palladia tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs
Contra-indications
Do not use in dogs used for breeding, or for pregnant or lactating bitches
Route of administration and dosage
Administer an initial dosage of 3.25 mg/kg (1.48 mg/lb) body weight, orally every other day (see Table 1). Dose reductions of 0.5 mg/kg (to a minimum dose of 2.2 mg/kg (1.0 mg/lb) every other day) and dose interruptions (cessation of PALLADIA for up to two weeks) may be utilized, if needed, to manage adverse reactions (see Table 2 as well as Warnings and Precautions). Adjust dose based on approximately weekly veterinary assessments for the first 6 weeks and approximately every 6 weeks, thereafter. PALLADIA may be administered with or without food. Do not split tablets.